Stay updated on PRC-063 vs Lisdexamfetamine in Adult ADHD Driving Clinical Trial
Sign up to get notified when there's something new on the PRC-063 vs Lisdexamfetamine in Adult ADHD Driving Clinical Trial page.

Latest updates to the PRC-063 vs Lisdexamfetamine in Adult ADHD Driving Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe ClinicalTrials.gov page now displays the completed Phase 3 study record comparing PRC-063 and lisdexamfetamine for driving performance in adults with ADHD, including its design, eligibility criteria, outcomes, and record dates, rather than an error page.SummaryDifference42%

- Check20 days agoChange DetectedThe footer revision identifier changed from v3.7.2 to v3.8.0 on the error page.SummaryDifference0.2%

- Check27 days agoChange DetectedA banner announces that NIH is transitioning from the term “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.SummaryDifference1%

- Check34 days agoChange DetectedThe footer revision label changed from v3.7.1 to v3.7.2 on the ClinicalTrials.gov 403 error page.SummaryDifference0.2%

- Check41 days agoChange DetectedThe footer’s ClinicalTrials.gov revision identifier changed from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check62 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the expected study content with an access-denied message. The HTML snippet includes the 403 header and a Home link, along with a site revision note, indicating restricted access rather than the usual study details.SummaryDifference17%

Stay in the know with updates to PRC-063 vs Lisdexamfetamine in Adult ADHD Driving Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PRC-063 vs Lisdexamfetamine in Adult ADHD Driving Clinical Trial page.